Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5700435 | Clinical Radiology | 2017 | 6 Pages |
Abstract
A significant reduction in CV and DLP during intracranial CTA can be achieved when employing a patient-specific contrast medium formula.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
C. Saade, G. Al-Fout, A. Mayat, P.C. Brennan, F. Hui, G. Maroun, R.N. Kikano, L. Naffaa,